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A key feature of many pathogenic microorganisms is the presence of a dense glycocalyx
at their surface, composed of lipid-anchored glycoproteins and non-protein-bound
polysaccharides. These surface glycolipids are important virulence factors for bacterial,
fungal and protozoan pathogens. The highly complex glycoconjugate lipophosphoglycan
(LPG) is one of the dominant surface macromolecules of the promastigote stage of all
Leishmania parasitic species. LPG plays critical pleiotropic roles in parasite survival and
infectivity in both the sandfly vector and the mammalian host. Here, we review the
composition of the Leishmania glycocalyx, the chemical structure of LPG and what is
currently known about its effects in the mammalian host, specifically. We will then discuss
the current approaches employed to elucidate LPG functions. Finally, we will provide
a viewpoint on future directions that this area of investigation could take to unravel in
detail the biological activity of the specific molecular elements composing the structurally
complex LPG.
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THE LEISHMANIA SURFACE COAT
Like all the parasites of the Trypanosomatid family, Leishmania is
characterized by the presence of a glycocalyx covering the entire
parasite surface (Ferguson, 1999). The surface coats of these dif-
ferent trypanosomatid parasites exhibit a significant diversity in
composition. However, all of the surface-bound molecules of this
family share a common structural feature, which is that they all
contain a highly conserved glycosylphosphatidylinositol (GPI)-
anchor motif. Notably, this type of GPI-lipid anchor is unusual
and structurally very different from those found in mammalian
cells (Mcconville and Ferguson, 1993).
Unlike other trypanosomatids in which the glycocalyx is
primarily composed of GPI-anchored glycoproteins, the glyco-
calyx of the Leishmania promastigote stage is dominated by
GPI-anchored phosphoglycosylated glycans. Lipophosphoglycan
(LPG) represents one of the most abundant promastigote-
specific surface glycoconjugates, with approximately 5 × 106
copies/cell (Turco and Descoteaux, 1992). The glycosylinositol
phospholipids (GIPLs) also termed free GPI, constitute a com-
plex family of abundant low-molecular-weight molecules, with
approximately 107 copies/cell. Three different types of GIPL
molecules have been described based on the nature of their gly-
can moiety (Mcconville et al., 1993). In the GIPL of type 1,
the glycan part is structurally similar to that of the LPG gly-
can core, whereas in the GIPL of type 2, the glycan part is
related to that of the GPI-anchored glycoprotein. The GIPLs of
type 3 exhibit features of type 1 and 2. The membrane-bound
proteophosphoglycans (mPPGs) represent a distinct family of
GPI-anchored protein-linked glycans that express a phospho-
glycan domain structurally similar to LPG. The mPPGs are
significantly expressed at the promastigote parasite surface but
to a lesser proportion than LPG and GIPLs (Ilg, 2000). Last,
one of the major GPI-anchored glycosylated proteins present at
the promastigote plasma membrane is GP63, with around 5 ×
105 copies/cell. Importantly, the composition of the Leishmania
surface glycocalyx changes dynamically during the life cycle of
the parasite. When infective, promastigote parasites differenti-
ate into obligate intracellular amastigotes in the infected mam-
malian host cell, the expression of LPG is drastically downreg-
ulated. In contrast, GIPLs and PPGs remain highly expressed
throughout the parasite life cycle (Turco and Sacks, 1991).
Notably, the PPGs continue to be produced in amastigotes, but
as free macromolecules rather than membrane-associated ones
(Bahr et al., 1993).
The glycoconjugates of the Leishmania promastigote mem-
brane are evenly distributed over the entire parasite surface. They
form a highly hydrophilic barrier easily detected as an electron-
dense material using electron microscopy. Its thickness can reach
up to 15 nm due to the length of the LPG polysaccharide chain
and potentially up to several hundred nanometers due to the
lengths of the mPPGs (Ilg, 2000). Because of their abundance,
structural uniqueness and specific distributions, the Leishmania
membrane glycoconjugates are believed to play important func-
tions in the mammalian host. Among these compounds, LPG has
attracted considerable attention because its clear implication in
multiple activities that favor parasite virulence.
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LEISHMANIA LPG STRUCTURE
Leishmania LPG, is a highly complex macromolecule composed
of four distinct domains: a GPI anchor, a glycan core, a lin-
ear phosphoglycan chain (PG) and a terminating oligosaccha-
ride cap (Figure 1) (Turco and Descoteaux, 1992). The GPI
anchor domain consists of an alkyl phosphatidylinositol hav-
ing a single saturated C24−26 aliphatic chain (Ferguson, 1999).
The LPG glycan core is a heptasaccharide comprising two galac-
topyranosides, a galactofuranoside (Galf), two mannosides and
a glucosamine residue attached to inositol. The glycan core is
linked to a linear PG that consists of 15–40 phosphodisaccha-
ride (Galβ1,4Manα1-PO4) units. Finally, LPG is terminated by a
di-, tri- or tetrasaccharide consisting of galactose and mannose
assembled as Manα1,2Manα1 or as Galβ1,4(Manα1,2)Manα1
depending on the Leishmania species.
The lipid anchor, glycan core and the linear PG moieties
that constitute the LPG are identical in all Leishmania species
(Descoteaux and Turco, 1999). Despite conservation of these
domains, however, LPG exhibits substantial heterogeneity, with
important parasite stage- and species-modifications found in the
oligosaccharide cap and in the substituents groups branched on
the linear PG (Turco et al., 2001; De Assis et al., 2012). Stage-
specific variations are observed throughout the parasite life cycle
such that LPG undergoes considerable structural modifications
in the PG and the terminating cap during parasite metacycloge-
nesis (Sacks et al., 1990, 1995). In the PG domain, the number
of repeating units increases such that the metacyclic promastig-
ote LPG is significantly longer than the procyclic promastigote
LPG. In the oligosaccharide cap, change is made with the replace-
ment of the galactoside residue by an arabinopyranoside residue.
Species-specific variations occurring in the PG domain of the
LPG are one of the main features of this virulent factor. Three
types of LPG have been described depending on the nature of
the side chain residues and on the site of substitution occupied
by these residues in the PG domain. The LPG of L. donovani
has no side substitution in the PG and therefore remains lin-
ear (Sacks et al., 1995). The LPGs of L. major, L. mexicana,
L. infantum, and L. tropica are glycosylated at the C3 position
of the galactose in the linear PG (Soares et al., 2002) and the
LPGs of L. aethiopica are frequently mannosylated at position
C2 of the mannose. Additionally, the variability in the sugar
residues that branch on the PG domain increases significantly
FIGURE 1 | Structure of the Leishmania LPG. Top and bottom panels show
two different representations of the LPG structure of Leishmania parasite. LPG
is constituted of four key domains. The GPI anchor and the glycan core are
shown in red. The linear conserved phosphoglycan chain is in blue. The
terminating oligosaccharide cap is shown in pink. In each domains, the residues
that are not conserved among the LPG of the different Leishmania species are
represented in a different color (Man, X, Y and Glc). The Glucose phosphate
branched on themannose residue of the glycan core (in green) is present in the
LPG of L. donovani, L.mexicana and some subspecies of L. major but absent in
some other subspecies. The linear phosphoglycan chain of L. donovani can be
substituted with different residues. X represents the substitutent group
express in the LPG L. mexicana, L. major and L. tropica. Y is a substitutent
present in the LPG of L. aethopica. Gal, galactose; Man, Mannose; Glc,
glucose; Galf, galactofuranose; GlcN, glucosamine; Ino, inositol.
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the level of LPG complexity. Finally, intraspecific LPG variabil-
ity has been observed among similar Leishmania species obtained
from different field isolates (Coelho-Finamore et al., 2011). Such
stage-specific polymorphisms and intra- and interspecies vari-
ations have been involved in the survival of Leishmania inside
the sand fly, more precisely in the selectivity, permissivity, and
competence of a given sand fly vector for particular Leishmania
strains (Dobson et al., 2006, 2010; Volf et al., 2014). However,
the role and the biological relevance of LPG polymorphism in the
mammalian host has been poorly understood.
Given the structural complexity and heterogeneity of LPG
molecules, the identification of the molecular elements respon-
sible for its biological activity have only partially been resolved.
ROLE OF LPG IN LEISHMANIA INTERACTIONS WITH THE
IMMUNE SYSTEM
The LPG-enriched glycocalyx of Leishmania constitutes the pri-
mary interface of the host-parasite interactions that take place
in the dermis of the mammalian host immediately after para-
site inoculation by the sandfly vector. Consequently, LPG is the
first target for immune detection and at the same time a bar-
rier protecting the parasite from the attack of the host immune
system.
LPG has been shown to circumvent the lysis of the parasite
by the host complement system. It acts either by sterically pre-
venting the attachment of complement molecules or by directly
inactivating the assembly of a functional complement complex at
the promastigote surface (Puentes et al., 1989, 1990).
LPG has been shown to favor intracellular parasite survival
by interfering with the pro-inflammatory host cell responses via
binding of Toll-like receptor (TLR) 2 and 4 on macrophages and
NK cells (Becker et al., 2003; De Veer et al., 2003; Kavoosi et al.,
2009; Rojas-Bernabe et al., 2014). LPG-TLR interactions induce
ERK phosphorylation while suppressing p38 MAP kinase phos-
phorylation, modulate the production of reactive oxygen species
and nitric oxide and inhibit pro-inflammatory cytokine secretion
(Chandra and Naik, 2008; De Assis et al., 2012). These studies
showed that the integrity of the lipid anchor as well as the length
of the PG domain of LPG are involved in the magnitude of LPG-
mediated host cell activation via TLR2, as procyclic promastigotes
are weaker stimulators than metacyclic promastigotes. The level
of LPG expression is also been considered as a critical param-
eter of this specific host cell stimulation pathway (Srivastava
et al., 2013). Given that the GPI anchor of trypanozoma cruzi has
been implicated in TLR2-mediated activation, it is conceivable
than the analogous site in Leishmania LPG play a similar func-
tion (Campos et al., 2001). Finally, by comparing the LPG from
L. braziliensis and L. infantum a recent study reveals that inter-
species LPG structural polymorphism has a significant impact on
host cell stimulation via TLR (De Assis et al., 2012; Ibraim et al.,
2013) Despite these advances, it remains to be determined which
LPG motifs are exactly implicated in TLR binding and further
immune cell stimulation.
The role of LPG during parasite internalization and multi-
plication within the host cell has been extensively studied but
they have yielded contradictory results. For instance LPG has
been shown to delay the maturation of the parasite-containing
phagosome by preventing its fusion with lysosomes while some
groups have demonstrated that such phenomenon does not occur
(Desjardins andDescoteaux, 1997; Forestier et al., 2011). In paral-
lel, LPG has been found to block the assembly of NADPH oxidase
and prevent recruitment of proton ATPases at the phagosomal
membrane (Lodge and Descoteaux, 2005; Vinet et al., 2009). This
function has been attributed to the localization of LPG at the
membrane of the Leishmania-containing phagosome (Dermine
et al., 2005; Winberg et al., 2009) (Figure 2). Therefore investigat-
ing a potential correlation between the intracellular localization
of LPG inside the host cells and a particular biological function
would require to be explored. Since the first observation of the
presence of the PG disaccharide repeat units of the LPG at the sur-
face of infected host cells (Tolson et al., 1990), a phenomenon that
was later confirmed by our group (Forestier, 2013), the fate and
pattern of trafficking of LPG during the infection process remain
elusive. Given this lack of knowledge, monitoring LPG traffick-
ing in the host cell and in the host organism during the infection
process will be key to better understand LPG functions in its
mammalian host. Furthermore, investigating whether chemical
modifications of LPG occur during the infection process will help
unraveling the importance of the distinct LPG structural motifs
on its biological functions.
LPG AS A PROMISING VACCINE CANDIDATE
Despite its lack of strong immunogenicity but because of its
unique structure, dense distribution and accessibility, Leishmania
LPG has been considered as an attractive vaccine target (Goel
et al., 1999). Early vaccine studies indicated that purified LPG
provides protection in mice against challenge with virulent par-
asites. These studies have demonstrated that LPG-mediated pro-
tection can be obtained with LPG alone and that its efficacy
depended on the integrity of the LPG molecule and could be
modulated by the use of adjuvants (Handman andMitchell, 1985;
Russell and Alexander, 1988; Mcconville and Ferguson, 1993;
FIGURE 2 | Localization of LPG at the membrane of the
Leishmania-containing phagosome. Bone marrow macrophages were
infected with L.donovani promastigote for 1 h at 37◦C then macrophages
were washed to remove extracellular parasites and incubated in new
medium for 24 h. Infected cells were processed for immunofluorescence
staining. The LPG molecules were stained using the anti-PG antibody
CA7AE (Red), the lysosome and phagosome compartments were stained
using the anti-LAMP-1 antibody (Green), the host cell and the parasite
nuclei were stained using the Hoechst dye (Blue). Images are analyzed
using the Imaris software. (A) Represents a single Z section of 0.7μm. (B)
Represents a zoomed image area of (A). Panel (C) is a 3D reconstruction of
the entire Z stack. Arrow points to two Leishmania-containing vacuoles
showing LPG at the phagosomal membranes. Scale bar, 10μm.
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Karanja et al., 2011). Contradictory results have arisen in more
recent studies, in both protective and disease-promoting effects
associated with LPG vaccination have been observed. These stud-
ies have revealed the importance of the immunization route in
the vaccine outcome, with subcutaneous LPG injection failing to
protect mice against L. amazonensis but intranasal administration
of LPG showing to be protective (Pinheiro et al., 2005, 2007).
Although the mechanisms of LPG-mediated immunization are
yet not known, LPG has been shown to activate T cells and favor
a Th1 immune response thus mediating protection against the
intracellular stage of Leishmania (Handman and Mitchell, 1985;
Moll et al., 1989; Moll and Rollinghoff, 1991; Tonui et al., 2003;
Amprey et al., 2004). Paradoxically, a recent study showed that
LPG vaccination, depending on the dose of LPG, induces the
expression of the inhibitory receptors PD-1 and PD-L2 on T cells
and macrophages respectively, therefore preventing proper pro-
tection against leishmaniasis (Martinez Salazar et al., 2014). Given
the structural complexity of LPG, it remains unknown which
feature of this glycoconjugate, independently or as a part of the
whole macromolecule, is involved in the effective immunization
process. Therefore, it is important to identify the functionally rel-
evant molecular elements of LPG with the goal of developing
artificial and well-designed LPG-based vaccines (Routier et al.,
1999; Hewitt and Seeberger, 2001; Astronomo and Burton, 2010;
Topuzogullari et al., 2013).
APPROACHES TO ASSESS LPG FUNCTIONS
The involvement of Leishmania LPG in virulence has been
confirmed in non-physiological conditions, using purified LPG
molecules tested on macrophages in vitro and, in a more biologi-
cally relevant context, using parasites defective in specific steps of
the LPG biosynthesis pathway.
Although the use of purified LPG has been very valuable to
unravel LPG functions, it also has several drawbacks. Among
these is the complicated purification procedures that it requires
and along with it the difficulty of obtaining pure LPG prepa-
rations devoid of various contaminants. More problematic is
the possibility that LPG preparation may become contaminated
with trace amount of endotoxin, a problem commonly faced
with the purification of molecules and that will greatly bias the
host cell immune response. Finally, the use of purified LPG does
not reflect the physiological conditions experienced in host cell-
parasite interaction, and the dose of LPG used in such artificial
functional assays may not replicate that encountered in actual
physiological conditions.
Genetic approaches rely on the identification of genes encod-
ing for enzymes that are involved in LPG biosynthesis, on the
disruption of these target genes in Leishmania and on the analysis
of the phenotypes and functions of such null mutants (Beverley
and Turco, 1998). This type of studies has led to the genera-
tion of parasites displaying LPG molecules that are truncated
at different levels of their polysaccharide moieties. Leishmania
parasites were generated with mutations in the LPG1, LPG2,
LPG5, and LPG3 genes that, respectively, encodes a galactofu-
ranosyltransferase involved in the synthesis of the LPG glycan
core specifically (Ryan et al., 1993), a Golgi GDP-mannose trans-
porter required for the synthesis of the PG domain common to
LPG and mPPG (Ma et al., 1997), a Golgi UDP-Gal transporter
critical for the synthesis of the PG (Capul et al., 2007a,b) and
the Leishmania homolog of a mammalian endoplasmic reticu-
lum chaperone required for complete PG synthesis (Descoteaux
et al., 2002). As a result, lpg1− parasites express intact GIPLs and
mPPG molecules, whereas LPG molecules have a truncated gly-
can core and no PG domain neither terminal oligosaccharide cap
(Spath et al., 2000). In contrast, lpg2− and lpg5− parasites express
normal GIPLs but these parasites lack all PG domains including
those of LPG and mPPG; however LPG molecules have a normal
glycan core (Spath et al., 2003; Liu et al., 2009). Finally, lpg3− par-
asites express LPG molecules truncated after the first mannoside
residue of the first disaccharide unit composing the PG domain
(Descoteaux et al., 2002).
These null-mutant parasites and others recent LPG-mutants
(Phillips and Turco, 2014) provide powerful tools for identify-
ing the functions of the LPG in a context that closely mimics
the natural course of infection, including a physiological concen-
tration of LPG interacting with the host. Importantly, analyses
of these mutants have been proven to discriminate efficiently
between the roles of LPG and those of other related glyco-
conjugates, including mPPG, that express similar polysaccharide
domains. Nevertheless, the nature of the lpg1, lpg2, lpg3, and lpg5
mutants offers the possibility of assessing the biological activ-
ity of only the LPG polysaccharide domains including the last
three sugar residues of the glycan core, the phosphoglycan dis-
accharide repeating units and the oligosaccharide cap. To the best
of our knowledge, the functional impact of the species-specific
substituents of the PG domain and the nature and structure of
the GPI anchor has not been yet investigated. Most likely, this
reflects the difficulty inherent in engineering parasites deficient
in such specific and essential structural motifs. Indeed, such an
approach requires first the identification of the specific genes
involved in the addition of the substituent to the linear PG and
involved in GPI-anchor biosynthesis and then the mutation of
these genes, to obtain viable parasites expressing modified gly-
coconjugates. Previous attempts to generate GPI-null Leishmania
have demonstrated that this domain is critical for parasite via-
bility and infectivity (Ilgoutz et al., 1999; Garami et al., 2001).
In contrast, parasites deficient exclusively in the assembly of the
GPI-anchored glycoproteins but not in the expression of LPG or
GIPLs retain their capacity to grow and remain virulent (Mensa-
Wilmot et al., 1994; Hilley et al., 2000; Zufferey et al., 2003).
However, these studies were not able to discriminate between
the GPI-anchor of LPG and other related structures carried by
the other glycoconjugates featuring the Leishmania surface. To
achieve a complete map of LPG structure-function relationships,
it is critically required to identify genes involved specifically in the
different steps of LPG biosynthesis, so that new LPGmutants may
be generated.
Nevertheless, despite the valuable information gained by these
studies, the main limitation of such genetic approaches is the lim-
ited opportunity they afford to investigate in detail and indepen-
dently the relative roles of the different structural motifs of highly
complex LPG molecules (oligosaccharide cap, phosphopolysac-
charide chain, glycan core, GPI anchor and fatty acid chain).
Although LPGs display high levels of heterogeneity, whether the
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molecular composition of the LPG motifs plays a distinct role
in LPG function has never been determined. Therefore, there is
an urgent need to explore the relative implications and contri-
butions of the different LPG molecular elements to its biological
activity.
FUTURE APPROACHES
In our point of view, one of the priorities for future research into
the functions of LPG is to elucidate the structure-activity rela-
tionship of this membrane-bound glycoconjugate. The ultimate
goal is to identify which LPG motifs are associated with specific
effects in the mammalian host. Such informations are expected
to bring key new insights into the mechanism of action of this
macromolecule.
To overcome some aspects of the limitations linked to the
genetic approaches, alternative methods that will aim to dis-
sect the LPG functional groups at the molecular level will need
to be developed. Chemical synthesis of such structurally com-
plex glycoconjugates may be one of the promising experimen-
tal approaches for investigating the distinct functions of each
of the structural elements that compose the multifunctional
LPG molecules. With technological advances in chemistry, new
synthetic strategies and methods for the chemical synthesis of
highly complex glycoconjugates are currently developed which
will make conceivably the synthesis of LPG feasible (Astronomo
and Burton, 2010). These chemical synthesis methods will allow
the design and production of panels of synthetic LPG variants
having independent molecular variations within its four distinct
domains. Such synthetic LPG compounds will be crucial tools
for investigating the functional relevance of the molecular ele-
ments of LPG. Using chemical synthesis one could expect to
address and elucidate the importance of (i) the composition of the
fatty acid chain of the GPI-anchor; (ii) the glycan core; and (iii)
the repetitive units in the PG domain. Comparisons among the
chemically well-defined collection of LPG variants will allow us to
assign a molecular motif to a biological function. Such chemical
synthesis methodology-based research could be extended to the
study of all the others GPI-anchored glyconconjugates expressed
at the cell surface of Leishmania and others related parasites.
This will include GIPLs that unlike LPG, is expressed both at
the promastigote and amastigote parasite stages and for which
information about its role in the mammalian host remains very
limited.
This type of approach will significantly advance our knowl-
edge of the structurally complex LPG. Significantly, it will
help to dissect the various LPG domains and attribute a pre-
cise function to each specific LPG elements, thereby estab-
lishing a causal structure-activity relationship. Ultimately, such
chemistry-based strategy will open new venue to the develop-
ment of LPG-based therapeutics agents against Leishmaniasis
using synthetic and biologically relevant molecular elements
of LPG.
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